20Jan 2021
ACEi reduces hypertension-induced hyperinflammation in COVID-19

ACEi reduces hypertension-induced hyperinflammation in COVID-19

Hypertension is associated with a pro-inflammatory state that worsens the prognosis of patients with coronavirus disease 2019 (COVID-19). According to a new study, antihypertensive blockade of the renin–angiotensin–aldosterone system (RAAS), particularly with the use of an angiotensin-converting enzyme inhibitor (ACEi), might improve outcomes in patients with hypertension and COVID-19.

  • #cardiology

Like

Save

Share